General Information

Samuel C. Fortin Pharma Inc.

	Address	235, Route Du Fleuve Ouest Ste-Luce, G0K 1P0 Canada
	Address type	Registered Office Address
	Address province	Quebec

	Corporation ID	7144971
	Business number	813879020
	Status	Active
	ACT	Canada Business Corporations Act
	Anniversary date	03/24/2009
	Last annual filing	2026
	Data verified	10/31/2026

Description

Samuel C. Fortin Pharma Inc. is an active establishment which was registered under Canada Business Corporations Act with a corporation no 7144971 (business number 813879020). The incorporation was performed on 2009-03-24. The company is based in Ste-Luce at 235, Route Du Fleuve Ouest, G0K 1P0 in Quebec province. As far as we managed to establish, the latest yearly meeting was held on 2017-03-09.
Additional enterprises in the proximity are: Samuel C. Fortin (Scf) Santé Inc., Gestion Scf Inc., Nutrocéan Inc., Datran Bas St-Laurent Inc., Les Immeubles Chow & Gagné Inc..

Company names

Name	Effective date	Type	Current
Samuel C. Fortin Pharma inc.	03/24/2009	Corporate Name	true

Directors

SAMUEL FORTIN
,

last updated: 2026-11-05

Individuals with Significant Control

Individuals who own, control or direct 25% or more of the shares, or have control in fact over the corporation, as reported to Corporations Canada.

samuel fortin
Sainte-Luce QC
More than 75% of the shares
Owns, controls or directs 25% or more of shares
Holds shares: directly · Control: individually
Since: 03/24/2009

reported to the registry: 05/25/2026 · last checked: 11/05/2026

Annual Filings

Type of corporation	Non-distributing corporation with 50 or fewer shareholders
Annual filing period (MM-DD)	03-24 to 05-23
Last annual meeting	02/22/2026

Year	Annual return
2026	Filed
2025	Filed
2024	Filed

last checked: 11/05/2026

Government Grants and Contributions

1 federal grant and contribution in 2018 with a total value of $45,250.

Start date	Department and program	Value
12/10/2018	National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) ARP - Increased omega-3 monoglyceride inflammation resolution activity The biological activity of omega-3 requires selective oxidation by lipoxygenase enzymes. In order to increase the activity of omega-3 monoglycerides, we want to premetabolize them with the help of a plant enzyme.	$45,250

Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.

Company activities

Date	Type	Section
03/24/2009	Incorporation

Company annual return

Meeting date	Type of corporation	Year of filing
03/09/2017	Non-distributing corporation with 50 or fewer shareholders	2017
02/09/2016	Non-distributing corporation with 50 or fewer shareholders	2016
02/26/2015	Non-distributing corporation with 50 or fewer shareholders	2015